Date Published
Country
Source
Videos
close
- Reset All Filters
- 7 results found
- x @Forbes
- x @RT_com
- x @WEWS
- x Market-Access
- x OxyContin
-
Colorado Allows Importation Of Prescription Drugs In Hopes Of Achieving 75% Price Decrease
Colorado Governor signs bill that will allow importation of prescription drugs from countries other than Canada in an attempt to decrease drug price. -
Purdue Pharma Offer $4.28 Billion To Settle Opioid Lawsuits As Part Of Restructuring Plan
Oxycontin-maker Purdue Pharma has submitted its bankruptcy restructuring plan.Comments
No comments yet. Create an account and log in to post a comment.
-
Opioid Drug-maker Purdue Pharma Suppresses Negative Stories About its Painkiller
Documents have revealed that US drug-maker Purdue Pharma ran a campaign to suppress negative stories about its widely-prescribed opioid painkiller.Comments
No comments yet. Create an account and log in to post a comment.
-
PURDUE PHARMA COUGHS UP: Beginning of the End for U.S. Opioid Epidemic?
Mike Papantonio and Trial Lawyer Magazine editor Farron Cousins break down Oxycontin manufacturer Purdue pharma’s recent bankruptcy filing.Comments
No comments yet. Create an account and log in to post a comment.
-
‘Blood on their hands’: FDA Denounced by Insider
Comments
No comments yet. Create an account and log in to post a comment.
-
Pharmaceutical Company Lawsuit Reveals Behind the Scene Manipulations of Opioid Sales
A leading pharmaceutical company at the center of national opioid litigation in a Cleveland federal court is being accused of behind the scene manipulation of opioid sales in a separate lawsuit filed in Massachusetts.Comments
No comments yet. Create an account and log in to post a comment.
-
Pharmaceutical Company Lawsuit Reveals Behind the Scene Manipulations of Opioid Sales
A leading pharmaceutical company at the center of national opioid litigation in a Cleveland federal court is being accused of behind the scene manipulation of opioid sales in a separate lawsuit filed in Massachusetts.Comments
No comments yet. Create an account and log in to post a comment.
Comments